S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
NHI · National Health Investors
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
National Health Investors Inc (NHI)
NEW YORK STOCK EXCHANGE, INC.
Real Estate
$64.85
-1.45
(-2.19%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$64.85
$64.77
$66.42
52-WEEK RANGE
$64.85
$63.51
$91.38
What's happening
- NHI is down 2.19% today, trading at $64.85. — Live quote
- Volume today (8,264) is well below its 3-month average of 503,220. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $1.15 actual vs. $0.86 estimated (+34.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 7
Hold 4
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
NHI
-13.12%
vs S&P 500
-25.90%
1-YEAR RETURN
NHI
-12.80%
vs S&P 500
-27.36%
6-MONTH RETURN
NHI
-22.82%
3-MONTH RETURN
NHI
-18.19%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$1.15
Est. $0.86
BEAT +34.0%
2026-04-26 (Q1 2026)
$0.82
Est. $0.86
MISS -4.9%
2026-01-26 (Q4 2025)
$0.80
Est. $0.82
MISS -1.9%
2025-10-26 (Q3 2025)
$0.69
Est. $0.75
MISS -8.3%
Valuation Measures & Ratios
Enterprise Value4$4.47B
Forward P/E520.34
PEG Ratio63.60
Price / Sales (TTM1)7.48
Price / Book72.35
EV4 / Revenue10.36
EV4 / EBITDA19.41
Profit Margin38.60%
Operating Margin32.27%
Return on Equity (ROE8)10.96%
Return on Assets (ROA9)5.88%
Avg Volume (3M)503,220
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $3.64B | $3.85B | $3.61B | $3.09B | $3.17B |
| P/E | 21.96 | 26.71 | 27.22 | 22.91 | 24.58 |
| Price/Sales | 8.72 | 10.00 | 10.23 | 8.89 | 9.35 |
| Price/Book | 2.31 | 2.54 | 2.44 | 2.09 | 2.22 |
| EV/Revenue | 8.65 | 9.94 | 10.00 | 8.83 | 8.95 |
| ROE | 10.54% | 9.51% | 8.95% | 9.12% | 9.04% |
| ROA | 5.59% | 4.99% | 4.93% | 5.01% | 4.63% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,391,392
Change from Prior Settlement+19.18%
% of Float—
Days to Cover (Short Ratio)5.37
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 33.8% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 38.6%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -12.8%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-08-27; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on NHI
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $121.3M | $115.1M | $89.8M | $90.7M | $89.3M | $82.9M | $85.0M | $81.5M |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $55.7M | $40.1M | $32.9M | $37.0M | $34.2M | $28.5M | $35.3M | $30.9M |
| EPS (diluted) | $1.15 | $0.82 | $0.69 | $0.79 | $0.74 | $0.65 | $0.81 | $0.71 |
| EPS (basic) | $1.15 | $0.83 | $0.69 | $0.79 | $0.75 | $0.66 | $0.81 | $0.71 |
| Net margin | $46 | $35 | $37 | $41 | $38 | $34 | $41 | $38 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.96B | $2.89B | $2.80B | $2.69B | $2.70B | $2.78B | $2.61B | $2.46B |
| Total liabilities | $1.37B | $1.36B | $1.26B | $1.19B | $1.20B | $1.34B | $1.23B | $1.21B |
| Stockholders' equity | $1.57B | $1.51B | $1.52B | $1.48B | $1.48B | $1.43B | $1.37B | $1.23B |
| Cash & equivalents | $30.4M | $24.9M | $19.6M | $81.6M | $18.6M | $135.0M | $24.3M | $15.6M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $2.57B | $2.56B | $2.47B | $2.30B | $2.32B | $2.27B | $2.21B | $2.10B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $491.0K | $485.0K | $483.0K | $476.0K | $475.0K | $467.0K | $457.0K | $436.0K |
| Retained earnings | $2.84B | $2.79B | $2.75B | $2.71B | $2.68B | $2.64B | $2.60B | $2.56B |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $65.0M | $53.4M | $67.7M | $62.5M | $59.8M | $46.5M | $57.6M | $48.6M |
| Investing cash flow | -$43.4M | -$103.9M | -$187.0M | $41.7M | -$48.3M | -$75.5M | -$161.2M | -$1.6M |
| Financing cash flow | $3.9M | $55.8M | $57.3M | -$41.9M | -$129.5M | $139.8M | $112.4M | -$46.2M |
| Free cash flow | — | — | -$226.3M | — | — | — | -$100.4M | — |
| Capital expenditures | — | — | $294.0M | — | — | — | $157.9M | — |
| Share-based compensation | — | — | — | — | — | — | — | — |
| Deferred income taxes | $732.0K | — | — | — | $0 | — | — | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Dividends paid | $44.6M | $44.4M | $43.8M | $42.7M | $42.0M | $41.1M | $39.3M | $39.1M |
| Share repurchases | — | — | — | — | — | — | $0 | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | $125.0M | $0 | $50.0M | $75.0M | $75.7M | $112.0K | $109.0K | $75.1M |
| Tax withholding on stock comp | $683.0K | $4.5M | $41.0K | $224.0K | $63.0K | $128.0K | $0 | $5.4M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $375.6M | $335.2M | $319.8M | $278.2M | $298.7M |
| Operating income | — | — | — | — | — |
| Net income | $142.2M | $138.0M | $135.7M | $66.4M | $111.8M |
| EPS (diluted) | $3.02 | $3.13 | $3.13 | $1.48 | $2.44 |
| EPS (basic) | $3.03 | $3.14 | $3.13 | $1.48 | $2.45 |
| Net margin | $38 | $41 | $42 | $24 | $37 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.80B | $2.61B | $2.49B | $2.51B | $2.84B |
| Total liabilities | $1.26B | $1.23B | $1.21B | $1.22B | $1.32B |
| Stockholders' equity | $1.52B | $1.37B | $1.25B | $1.27B | $1.51B |
| Cash & equivalents | $19.6M | $24.3M | $22.3M | $19.3M | $37.4M |
| Accounts receivable | — | — | — | $3.6M | $3.2M |
| Property, plant & equipment | $2.47B | $2.21B | $2.11B | $2.12B | — |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $483.0K | $457.0K | $434.0K | $434.0K | $459.0K |
| Retained earnings | $2.75B | $2.60B | $2.47B | $2.33B | — |
| Accumulated other comprehensive income (loss) | — | — | — | — | $0 |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $236.6M | $207.8M | $184.4M | $185.3M | $210.9M |
| Investing cash flow | -$269.1M | -$192.3M | -$11.6M | $197.9M | $185.3M |
| Financing cash flow | $25.7M | -$13.6M | -$169.7M | -$401.3M | -$403.0M |
| Free cash flow | -$57.5M | $49.8M | $134.9M | $174.3M | $160.5M |
| Capital expenditures | $294.0M | $157.9M | $49.6M | $11.0M | $50.3M |
| Share-based compensation | — | — | — | — | — |
| Deferred income taxes | — | — | — | — | — |
| Change in accounts receivable | — | — | — | — | — |
| Purchases of investments | — | — | — | — | — |
| Dividends paid | $169.7M | $156.5M | $156.2M | $161.8M | $182.9M |
| Share repurchases | — | $0 | $0 | $152.0M | $0 |
| Debt repaid | $200.8M | $75.4M | $415.4M | $135.4M | $293.3M |
| Tax withholding on stock comp | $456.0K | $5.8M | $0 | $288.0K | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding NHI as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-17 to 2026-07-27
Recent transactions
- Insiders have net bought 2,390 shares over the last 182 days, across 2 purchases and 0 sales.
- Most recent: Maingot Christian Ken (Chief Operating Officer) — Grant / award of 2,370 shares on 2026-07-27.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)2,390 sh(2 txns)
Sales (open market)0 sh(0 txns)
Net Shares+2,390
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Maingot Christian Ken | Chief Operating Officer | Grant / award | 2026-07-27 | 2,370 |
| MCCABE ROBERT A JR | Director | Open market purchase | 2026-06-15 | 890 |
| Jobe James R | Director | Gift | 2026-06-05 | 225 |
| Mendelsohn D. Eric | CEO and President | Open market purchase | 2026-06-05 | 1,500 |
| Spaid John L | CFO/EVP Finance | Tax withholding | 2026-05-05 | 314 |
| Travis David L | SVP/Chief Accounting Officer | Tax withholding | 2026-05-05 | 282 |
| Donohue Lilly | Director | Grant / award | 2026-03-03 | 1,268 |
| COLDEN TRACY M J | Director | Grant / award | 2026-03-03 | 1,268 |
| Todd Candice W | Director | Grant / award | 2026-03-03 | 1,268 |
| Chapin Robert | Director | Grant / award | 2026-03-03 | 1,268 |
| PASCOE KEVIN CARLTON | Chief Investment Officer | Grant / award | 2026-03-03 | 5,072 |
| Blankenship Elizabeth Jackson | SVP, Legal Affairs | Grant / award | 2026-03-03 | 2,420 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-27 | Maingot Christian Ken | Chief Operating Officer | Grant / award | 2,370 | $0.00 |
| 2026-06-15 | MCCABE ROBERT A JR | Director | Open market purchase | 890 | $71.65 |
| 2026-06-05 | Jobe James R | Director | Gift | 225 | $0.00 |
| 2026-06-05 | Mendelsohn D. Eric | CEO and President | Open market purchase | 1,500 | $68.84 |
| 2026-05-05 | Spaid John L | CFO/EVP Finance | Tax withholding | 314 | $73.09 |
| 2026-05-05 | Mendelsohn D. Eric | CEO and President | Tax withholding | 394 | $73.09 |
| 2026-05-05 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 282 | $73.09 |
| 2026-03-03 | Donohue Lilly | Director | Grant / award | 1,268 | $0.00 |
| 2026-03-03 | COLDEN TRACY M J | Director | Grant / award | 1,268 | $0.00 |
| 2026-03-03 | Todd Candice W | Director | Grant / award | 1,268 | $0.00 |
| 2026-03-03 | Chapin Robert | Director | Grant / award | 1,268 | $0.00 |
| 2026-03-03 | Jobe James R | Director | Grant / award | 1,268 | $0.00 |
| 2026-03-03 | MCCABE ROBERT A JR | Director | Grant / award | 1,268 | $0.00 |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Grant / award | 4,726 | $0.00 |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Tax withholding | 511 | $86.75 |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Option exercise | 15,000 | $73.34 |
| 2026-03-03 | Spaid John L | CFO/EVP Finance | Tax withholding | 13,594 | $86.75 |
| 2026-03-03 | PASCOE KEVIN CARLTON | Chief Investment Officer | Grant / award | 5,072 | $0.00 |
| 2026-03-03 | Mendelsohn D. Eric | CEO and President | Grant / award | 14,409 | $0.00 |
| 2026-03-03 | Mendelsohn D. Eric | CEO and President | Tax withholding | 597 | $86.75 |
| 2026-03-03 | Travis David L | SVP/Chief Accounting Officer | Grant / award | 3,458 | $0.00 |
| 2026-03-03 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 411 | $86.75 |
| 2026-03-03 | Blankenship Elizabeth Jackson | SVP, Legal Affairs | Grant / award | 2,420 | $0.00 |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Option exercise | 8,333 | $57.76 |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Option exercise | 8,333 | $57.76 |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Option exercise | 8,334 | $57.76 |
| 2026-02-23 | Travis David L | SVP/Chief Accounting Officer | Tax withholding | 19,322 | $90.03 |
| 2026-02-23 | PASCOE KEVIN CARLTON | Chief Investment Officer | Option exercise | 8,500 | $57.76 |
| 2026-02-23 | PASCOE KEVIN CARLTON | Chief Investment Officer | Tax withholding | 6,409 | $90.03 |
| 2026-02-23 | Mendelsohn D. Eric | CEO and President | Option exercise | 13,334 | $57.76 |
| 2026-02-23 | Mendelsohn D. Eric | CEO and President | Tax withholding | 10,192 | $90.03 |
| 2026-02-23 | Mendelsohn D. Eric | CEO and President | Tax withholding | 194 | $90.03 |
| 2026-02-23 | Spaid John L | CFO/EVP Finance | Option exercise | 8,500 | $57.76 |
| 2026-02-23 | Spaid John L | CFO/EVP Finance | Tax withholding | 6,312 | $90.03 |
| 2026-02-23 | Spaid John L | CFO/EVP Finance | Tax withholding | 236 | $90.03 |
| 2026-02-19 | COLDEN TRACY M J | Director | Option exercise | 10,000 | $73.34 |
| 2026-02-19 | COLDEN TRACY M J | Director | Tax withholding | 8,267 | $88.72 |
| 2026-02-17 | Mendelsohn D. Eric | CEO and President | Option exercise | 25,000 | $73.34 |
| 2026-02-17 | Mendelsohn D. Eric | CEO and President | Tax withholding | 22,055 | $91.02 |
| 2026-02-17 | Jobe James R | Director | Option exercise | 10,000 | $73.34 |
| 2026-02-17 | Jobe James R | Director | Tax withholding | 8,058 | $91.02 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:52 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-27 | 8-K | 2026-08-27 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-30 | 4 | 2026-07-27 | View on SEC.gov → |
| 2026-07-27 | 8-K | 2026-07-22 | View on SEC.gov → |
| 2026-07-01 | 8-K | 2026-07-01 | View on SEC.gov → |
| 2026-07-01 | 8-K | 2026-07-01 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-15 | View on SEC.gov → |
| 2026-06-09 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-05 | View on SEC.gov → |
Recent news
Headlines about NHI (National Health Investors). Links open the publisher — we don’t host full articles.
-
National Health Investors stock gains 4.42 percent at EUR 59.00
AD HOC NEWS · 2026-10-20 -
NHI Maintained by Wells Fargo -- Price Target Lowered to $68.00
GuruFocus · 2026-10-19 -
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68
Benzinga · 2026-10-19 -
National Health Investors price target lowered to $68 from $78 at Wells Fargo
TipRanks · 2026-10-19 -
National Health Investors stock last at USD 66.28 on October 16, 2026, P/ E 19.2
AD HOC NEWS · 2026-10-17 -
National Health Investors: This 5.7% Healthcare REIT Is A Hold (NYSE:NHI)
Seeking Alpha · 2026-10-17 -
National Health Investors trades at a discount ...
Pluang · 2026-10-17 -
National Health Investors: This 5.7% Healthcare REIT Is A Hold
SeekingAlpha · 2026-10-17
No headlines in this category right now — try “All”.